According to the study, the genes IKKE and TBK1 play an important role in maintaining the metabolic balance of the body. And amlexanox works by inhibiting two genes-IKKE and TBK1, and the drug seems to free the metabolic system to burn more, and possibly store less, energy.
Saltiel told ANI: “These studies tell us that, at least in mice, the IKKE/TBK1 pathway plays an important role in defending body weight by increasing storage and decreasing burning of calories, and by inhibiting that pathway with a compound, we can increase metabolism and induce weight loss, reverse diabetes and reduce fatty liver.”
The drug is available in Japan for more than 25 years, but it's not clear that how it responds on humans. If this drug shows effectiveness on human body then it will be boon for the treatment of obesity and diabetes in humans.
Apart from this, there is a firm need for culturally appropriate educational literature that tells us about the risk of eating badly and not doing exercises. A modified lifestyle will also help in avoiding such a health care crisis globally.
The most popular citizen journalists' reports on merinews chosen automatically on the basis of views and comments
View more jobs